Fang Qiu
36 Sanhao Street
Shenyang, China
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial.
Journal: Nature communications
Published: February 19, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet regional health. Western Pacific
Published: January 30, 2025
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer.
Journal: Nature communications
Published: July 27, 2022
Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.
Journal: Journal of applied clinical medical physics
Published: August 10, 2020
The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: January 25, 2019
Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Journal: BMC surgery
Published: November 23, 2013
A new technique that complements sentinel lymph node biopsy: lymph node dissection under the intercostobrachial nerves in early-stage breast cancer.
Journal: Clinical breast cancer
Published: August 17, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026